[Chemoembolization techniques for hepatocellular carcinoma in cirrhosis].
Transcatherter oily chemoembolisation, that should not be confused with other different and less effective techniques also called "chemoembolisation" is the most widely used therapy for loco-regional palliative treatment of hepatocellular carcinoma, which will become increasingly frequent, due to HCV infection; the cancer itself is often discovered at an advanced stage, when neoplastic extension precludes radical treatment that is liver transplantation. Performed with the best techniques, it offers a 1- and 5-yr survival of 60 and 30%, that is under confirmation by a randomized trial.
Vetter
D
D
Service d'Hépato-Gastroentérologie, Hôpitaux Universitaires de Strasbourg, Hôpital Civil.
Bronowicki
J P
JP
Doffoël
M
M
D006528:Carcinoma, Hepatocellular / Q000209:etiology / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D003287:Contrast Media; D004621:Embolization, Therapeutic / Q000379:methods*; D006801:Humans; D007459:Iodized Oil; D008103:Liver Cirrhosis / Q000150:complications*; D008113:Liver Neoplasms / Q000209:etiology / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D010166:Palliative Care; D016019:Survival Analysis; D016896:Treatment Outcome
D003287:Contrast Media; D007459:Iodized Oil